ArticleACS nano2026
Smart Microneedles Regulate Reactive Oxygen Species and Deliver Matrix Metalloproteinases for Pathological Scar Treatment.
Article in ACS nano, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Hydrogels as Local Structural-Protective Platforms in Rheumatoid Arthritis: An Evidence-Graded Review Across the Synovium-Cartilage-Bone Axis.Gels (Basel, Switzerland) · 2026Review
- Microneedle-Assisted Cell Delivery and Therapy.Research (Washington, D.C.) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Excessive oxidative stress and abnormal collagen deposition are critical drivers of pathological scar (PS) formation. To investigate the differences between normal and keloid tissues, single-cell sequencing and histological staining were conducted on patient samples, revealing that heightened collagen proliferation and oxidative stress are central to PS. To modulate the oxidative microenvironment and remodel the extracellular matrix (ECM), a smart microneedle capable of regulating reactive oxygen species (ROS) and delivering matrix metalloproteinase (MMP) functions was developed. Composed of methacrylated alginate hydrogel and hollow manganese dioxide nanoparticles, this microneedle not only scavenges ROS but also promotes the expression of genes and proteins associated with antioxidant and anti-inflammatory responses. Furthermore, MMP release from the ROS-responsive hydrogel suppresses transforming growth factor signaling, degrades excessive collagen, and facilitates ECM remodeling. In vivo evaluations in rabbit and porcine PS models demonstrated that this smart microneedle reduces scar thickness and restores skin function, highlighting its promising clinical potential. Overall, this study provides a clinically relevant framework for material design and establishes a closed-loop therapeutic strategy that integrates pathological signal decoding with targeted intervention, offering a approach for PS treatment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.